Article contents
Gastrointestinal Selective Capacity of Doripenem, Meropenem, and Imipenem for Carbapenem-Resistant Gram-Negative Bacilli in Treated Patients with Pneumonia
Part of:
BARRY FARR AWARD RECIPIENTS
Published online by Cambridge University Press: 02 January 2015
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS019594170004042X/resource/name/firstPage-S019594170004042Xa.jpg)
- Type
- Letters to the Editor
- Information
- Copyright
- Copyright © The Society for Healthcare Epidemiology of America 2011
References
1.
Peleg, AY, Seifert, H, Paterson, DL.
Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev
2008;21:538–582.10.1128/CMR.00058-07Google Scholar
2.
Paterson, DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis
2006;43(suppl 2):S43–S48.10.1086/504476Google Scholar
3.
Fishbain, J, Peleg, AY. Treatment of Acinetobacter infections. Clin Infect Dis
2010;51:79–84.Google Scholar
4.
Kang, CI, Kim, SH, Kim, HB, et al.
Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis
2003;37:745–751.10.1086/377200Google Scholar
5.
Micek, ST, Kollef, KE, Reichley, RM, Roubinian, N, Kollef, ME. Health care-associated pneumonia and community acquired pneumonia: a single-center experience. Anhmicrob Agents Chemother
2007;51:3569–3573.Google Scholar
6.
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI, 2009.Google Scholar
- 2
- Cited by